Stockreport

Oragenics, Inc. to Present at the 22nd Annual BIO CEO & Investor Conference

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN), a leader in the development of effective treatments for oral mucositis and new antibiotics again [Read more]